Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia.

energy metabolism glaucoma hypoxia metabolomics normal-tension glaucoma ocular hypertension oxygen stress

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Dec 2023
Historique:
received: 26 11 2023
revised: 20 12 2023
accepted: 20 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

Glaucoma is a neurodegenerative disease that affects the retinal ganglion cells (RGCs). The main risk factor is elevated intraocular pressure (IOP), but the actual cause of the disease remains unknown. Emerging evidence indicates that metabolic dysfunction plays a central role. The aim of the current study was to determine and compare the effect of universal hypoxia on the metabolomic signature in plasma samples from healthy controls (

Identifiants

pubmed: 38203366
pii: ijms25010195
doi: 10.3390/ijms25010195
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Jørgen Bagenkop Nielsens Eye-Foundation
ID : 117138, 117139, and 119012
Organisme : Øjenforeningen
ID : 115774, 113846, and 114065
Organisme : Synoptikfonden
ID : 117140 and 118012

Auteurs

Mia Langbøl (M)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.

Jens Rovelt (J)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, 2600 Glostrup, Denmark.

Arevak Saruhanian (A)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.

Sarkis Saruhanian (S)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Department of Veterinary & Animal Sciences, University of Copenhagen, 2000 Frederiksberg, Denmark.

Daniel Tiedemann (D)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, 2600 Glostrup, Denmark.

Thisayini Baskaran (T)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.

Cinzia Bocca (C)

Faculté de Santé, Institut MITOVASC, UMR CNRS 6015, INSERM U1083, Université d'Angers, 49933 Angers, France.
Département de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire (CHU), 49933 Angers, France.

Rupali Vohra (R)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, 2600 Glostrup, Denmark.

Barbara Cvenkel (B)

Department of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.

Guy Lenaers (G)

Faculté de Santé, Institut MITOVASC, UMR CNRS 6015, INSERM U1083, Université d'Angers, 49933 Angers, France.

Miriam Kolko (M)

Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, 2600 Glostrup, Denmark.

Classifications MeSH